AMLODIPINE | AMLODIPINE | ATC C09XA53 ATC C09XA54 ATC C08CA01 ATC C08CA51 ATC C08GA02 ATC C10BX03 ATC C10BX19 ATC C10BX11 ATC C10BX18 ATC C09BB13 ATC C07FB07 ATC C09DB07 ATC C09DX06 ATC C09DB09 ATC C09DB05 ATC C09DX07 ATC C09BB03 ATC C09DB06 ATC C07FB13 ATC C07FB12 ATC C09DB02 ATC C09DX03 ATC C09BB04 ATC C09BX01 ATC C09BX04 ATC C09BX06 ATC C09BB07 ATC C09BX03 ATC C10BX09 ATC C10BX07 ATC C10BX14 ATC C09DB04 ATC C09DX08 ATC C09DB01 ATC C09DX01
CARDIVASCULAR CALCIUM CHANNEL BLOCKER ANTIANGINALS ANTIHYPERTENSIVE AGENTS VASODILATOR AGENTS PYRIDINE CALCIUM ANTAGONIST (CALCIUM ION ANTAGONIST OR SLOW-CHANNEL BLOCKER) | ORAL | Tmax 8 HOUR F 77 PERCENT VD 1365 LITER (65 KILOGRAM) PPB 93 PERCENT Cl 27.3 LITER / HOUR (65 KILOGRAM) HT 40 HOUR SOLUBILITY SLIGHTLY SOLUBLE IN WATER | CALCIUM CHANNEL PDB 3TMZ (CRYSTAL STRUCTURE OF P450 2B4(H226Y) IN COMPLEX WITH AMLODIPINE) LIGAND CODE = 06X (link to the list of PDB complexes) Download experimental 3D coordinates of 06X with added hydrogens | Voltage-dependent L-type calcium channel subunit alpha-1C UNIPROT Q13936 CACNA1C -- Voltage-dependent L-type calcium channel subunit alpha-1D UNIPROT Q01668 CACNA1D more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |